1)Fujibayashi T, et al:Revised Japanese criteria for Sjögren's syndrome(1999);Availability and validity. Mod Rheumatol 14:425-434, 2004 PMID 24387718
2)Shiboski CH, et al;International Sjögren's Syndrome Criteria Working Group:2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome;A consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 76:9-16, 2017 PMID 27789466
3)Shiboski CH, et al;International Sjögren's Syndrome Criteria Working Group:2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome;A consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 69:35-45, 2017 PMID 27785888
4)Tsuboi H, et al:Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan. Mod Rheumatol 24:464-470, 2014 PMID 24252039
5)Tzioufas AG, et al:Autoantibodies in Sjögren's syndrome;Clinical presentation and regulatory mechanisms. Presse Med 41:e451-e460, 2012 PMID 22840991
6)坪井洋人,他:第3章 診断手技・手法 自己抗体.日本シェーグレン症候群学会(編):シェーグレン症候群の診断と治療マニュアル 改訂第3版,pp 83-91,診断と治療社,2018
7)Baer AN, et al;Sjögren's International Collaborative Clinical Alliance(SICCA)Research Groups: The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome. Ann Rheum Dis 74:1557-1561, 2015 PMID 25735642
8)Park Y, et al:Distinct clinical characteristics of anti-Ro/SSA-negative primary Sjögren's syndrome;Data from a nationwide cohort for Sjögren's syndrome in Korea. Clin Exp Rheumatol 37:S107-S113, 2019 PMID 31376264
9)Payet J, et al:ACPA-positive primary Sjögren's syndrome;True primary or rheumatoid arthritis-associated Sjögren's syndrome? RMD Open 1:e000066, 2015 PMID 26509066
10)坪井洋人,他:Sjögren症候群.日内会誌103:2507-2519, 2014
11)厚生労働科学研究費補助金難治性疾患等政策研究事業 自己免疫疾患に関する調査研究班(編):シェーグレン症候群診療ガイドライン2017年版,診断と治療社,2017